Hospitalizations for schistosomiasis in Spain by sex: a population-based study using the national hospital discharge database (2016–2023) Authors: Alberto Ramos-Belinchon, Silvia Otero-Rodriguez, Isabel Belinchon-Romero, José-Manuel Ramos-Rincon Published: 2026 ABSTRACT BackgroundSchistosomiasis is an emerging imported parasitic disease in Europe, but information on its clinical burden among hospitalized patients in non-endemic countries remains limited.ObjectiveTo describe the epidemiology, clinical characteristics, complications, and outcomes of patients hospitalized with schistosomiasis in Spain using nationwide hospital discharge data, with a focus on sex-related differences.MethodsWe conducted a retrospective observational study using the Spanish National Hospital Discharge Database (SNHDD). All hospitalizations with schistosomiasis (ICD-10: B65) recorded between 2016 and 2023 were included. Demographic characteristics, country of birth, clinical conditions, complications, and outcomes were analyzed. Urogenital, hepatosplenic, and intestinal complications were identified using ICD-10 codes.ResultsA total of 710 hospitalizations were identified; 550 (77.5%) occurred in men. Women were older than men (median age 46 vs. 34 years; p < 0.001) and had longer hospital stays (9 vs. 7 days; p = 0.041). Urogenital complications were more frequent in men, including bladder cancer (5.1% vs. 0.6%; p = 0.012), hematuria (5.8% vs. 1.3%; p = 0.017), cystitis (6.7% vs. 0.6%; p = 0.003), and obstructive uropathy (5.3% vs. 0%; p = 0.003). Male sex was independently associated with bladder cancer (aOR 16.31, 95% CI 2.12–125; p = 0. 0.007) and cystitis (adjusted OR 9.49, 95% CI 1.28–70; p = 0.028). Age was positively associated with bladder cancer (aOR 1.05, 95% CI 1.043–1.08; p < 0.001), and a lower probability of hematuria. (aOR 0.96, 95% CI 0.93–0.99; p = 0.005. In contrast, hepatosplenic complications were more frequent in women, including portal hypertension (12.5% vs. 4.5%; p < 0.001), esophageal varices (9.4% vs. 1.8%; p < 0.001), splenomegaly (5.6% vs. 1.5%; p = 0.002), and cirrhosis (6.3% vs. 2.7%; p = 0.033). Female sex was independently associated with portal hypertension (aOR 3.10, 95% CI 1.60–5.99), esophageal varices (aOR 7.11, 95% CI 2.92–17.30), and splenomegaly (aOR 5.46, 95% CI 1.88–15.92). ICU admission (8.6%) and in-hospital mortality (1.8%) did not differ significantly by sex. The overall hospitalization rate was 20 per million hospital admissions and was higher in men than in women (32.1 vs. 8.7 per million).ConclusionHospitalizations for schistosomiasis in Spain predominantly occur in men and are mainly associated with imported infections. Men more frequently present with urogenital complications, whereas women show a higher burden of hepatosplenic manifestations. These findings highlight the importance of increasing clinical awareness and implementing targeted screening and early diagnostic strategies in at-risk populations in non-endemic settings.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12879-026-13711-x. Introduction Schistosomiasis is one of the most important parasitic diseases worldwide, affecting more than 200 million people, particularly in sub-Saharan Africa. The infection is caused by trematodes of the genus Schistosoma, mainly Schistosoma haematobium and Schistosoma mansoni, which are responsible for urogenital and intestinal disease, respectively. Chronic infection may lead to severe complications such as hepatic fibrosis, portal hypertension, bladder pathology, infertility, and an increased risk of malignancy. Although the disease is endemic in tropical and subtropical regions, globalization, migration, and international travel have increasingly contributed to the diagnosis of schistosomiasis in non-endemic countries [1]. In Europe, and particularly in Spain, most cases occur among migrants from endemic regions and travelers returning from sub-Saharan Africa [2–4]. Several studies conducted in specialized tropical medicine units have highlighted that schistosomiasis is relatively frequent in certain high-risk populations [5]. Screening programs targeting migrants from endemic areas have shown a substantial burden of undiagnosed infection, supporting the need for systematic screening strategies in non-endemic settings [6]. Similarly, experience from referral tropical medicine units in Spain indicates that imported schistosomiasis is commonly diagnosed during outpatient evaluation of migrants and travelers, often in the context of screening or mild clinical symptoms rather than severe disease [5]. More recently, prospective population-based screening studies have demonstrated that chronic manifestations of schistosomiasis may remain underdiagnosed for years after migration. Male genitourinary symptoms related to S. haematobium infection have been described among long-term West African migrants living in Spain, highlighting the persistence of infection and the potential for chronic morbidity even decades after exposure [7]. Despite these advances in screening and outpatient diagnosis, little is known about the burden of schistosomiasis requiring hospitalization in non-endemic countries. Most studies in Europe have focused on outpatient cohorts from tropical medicine clinics, and data describing hospitalized patients are scarce. Hospitalized cases may represent a distinct subgroup of patients with more severe disease, complications, or relevant comorbidities [8]. In Spain, the Spanish National Hospital Discharge Database (SNHDD, Conjunto Mínimo Básico de Datos, CMBD) provides a valuable source of information to evaluate the epidemiology and clinical characteristics of infectious diseases requiring hospital care at a national level. The analysis of administrative databases has proven useful to assess the burden and outcomes of imported parasitic diseases in non-endemic settings [9, 10]. Therefore, the aim of this study was to describe the epidemiology, clinical characteristics, complications, and outcomes of patients hospitalized with schistosomiasis in Spain using nationwide hospital discharge data, with a particular focus on differences according to sex. By focusing on hospitalized cases, this study provides complementary information to outpatient screening studies and contributes to a better understanding of the clinical spectrum and healthcare impact of schistosomiasis in a non-endemic country. Materials and methods Study design and data source We conducted a retrospective observational study using data from the SNHDD. The SNHDD is an administrative database that collects standardized information on hospital admissions from public hospitals and most private hospitals within the Spanish National Health System. The database includes demographic characteristics, admission and discharge dates, diagnoses, procedures performed during hospitalization, and clinical outcomes at discharge. Diagnoses and procedures are coded according to the International Classification of Diseases, 10th Revision (ICD-10). The SNHDD covers more than 95% of hospital admissions in Spain and has been widely used in epidemiological studies to evaluate the burden, clinical characteristics, and outcomes of different diseases at the national level. Study population All hospital admissions recorded in the SNHDD with a diagnosis of schistosomiasis between 1 January 2016 and 31 December 2023 were included in the study. Cases were identified using ICD-10 diagnostic codes corresponding to schistosomiasis. These included schistosomiasis due to Schistosoma haematobium (ICD-10: B65.0), schistosomiasis due to Schistosoma mansoni (ICD-10: B65.1), schistosomiasis due to Schistosoma japonicum (ICD-10: B65.2), other schistosomiasis (ICD-10: B65.8), and unspecified schistosomiasis (ICD-10: B65.9). Hospitalizations were included regardless of whether schistosomiasis was coded as the primary diagnosis or as a secondary diagnosis. Diagnoses were identified from any of the diagnostic positions available in the database (DX1–DX20). Patients of all ages were eligible for inclusion in the study. Variables The SNHDD provides demographic and clinical information for each hospitalization episode. The variables analyzed included age, sex, year of hospitalization, and autonomous community of hospitalization. Age was analyzed both as a continuous variable and grouped into clinically relevant categories. Hospitalization-related variables included the circumstance of admission, categorized as programmed or non-programmed admission, length of hospital stay, admission to the intensive care unit, in-hospital mortality, and hospitalization cost. Length of hospital stay was calculated as the number of days between hospital admission and discharge. The costs of hospitalization per DRG are collected by the Spanish Health Ministry according to the DRG and are updated every year based on the real costs reported by the Spanish Statistical Office [11]. Clinical complications potentially related to schistosomiasis were identified using ICD-10 diagnostic codes recorded during hospitalization. Urogenital complications included bladder cancer (ICD-10: C67), hematuria (ICD-10: R31), cystitis (ICD-10: N30), obstructive uropathy (ICD-10: N13), prostatitis (ICD-10: N41), epididymo-orchitis (ICD-10: N45), acute kidney injury (ICD-10: N17), urinary tract infection and pyelonephritis (ICD-10: N39, N11), and chronic kidney disease (ICD-10: N18). Hepatosplenic complications included cirrhosis (ICD-10: K74), portal hypertension (ICD-10: K76.6), esophageal varices (ICD-10: I85), and splenomegaly (ICD-10: R16.1). Intestinal complications included colitis (ICD-10: K52), gastrointestinal bleeding (ICD-10: K92, K92.2). and colonic polyps (ICD-10: K63.5). All clinical entities and ICD-10 codes used to construct the variables are detailed in Table S1. Statistical analysis Categorical variables were expressed as absolute frequencies and percentages, whereas continuous variables were summarized as medians and interquartile ranges due to the non-normal distribution of most variables. Comparisons between groups were performed using the chi-square test or Fisher’s exact test for categorical variables and the Mann–Whitney U test for continuous variables. To evaluate temporal trends, annual hospitalization rates were calculated as the number of hospitalizations with schistosomiasis per 1,000,000 total hospital admissions recorded in the SNHDD for each year of the study period. To analyze the geographic distribution of hospitalizations, hospitalization rates by autonomous community were calculated as the number of schistosomiasis-related hospitalizations per 100,000 hospital admissions registered from 2016 to 2023 in each autonomous community. The denominators used to calculate hospitalization rates correspond to the total number of hospital admissions recorded in the SNHDD for each year of the study period and, for the regional analysis, to the total number of hospital admissions registered in each autonomous community from 2016 to 2023. To identify factors independently associated with genitourinary and hepatosplenic complications, binary logistic regression models were constructed. Variables with a p value < 0.05 in the univariate analysis were included in the multivariable models using a forward stepwise (likelihood ratio) selection procedure. Collinearity between variables was assessed prior to model construction. Adjusted odds ratios (aORs) with 95% confidence intervals (95% CIs) were calculated. A two-tailed p value of less than 0.05 was considered statistically significant. All statistical analyses were performed using SPSS version 25 (IBM Corp., Armonk, NY, USA). Ethical considerations This study was conducted using anonymized data from the SNHDD, a nationwide administrative registry used for research purposes that does not contain identifiable patient information. As the study was based exclusively on fully anonymized retrospective data, informed consent from individual patients was not required. The research protocol was approved by the Committee of Ethics and Integrity in Research of Miguel Hernández University (ref. AUT.DMC.JMRR.260310). All procedures adhered to the ethical standards outlined in the revised Declaration of Helsinki (2013). Results A total of 710 hospitalizations with schistosomiasis were identified in Spain between 2016 and 2023. Most admissions occurred in men (550 cases, 77.5%), whereas 160 cases (22.5%) were recorded in women. Only 50 patients (7.0%) were aged ≤ 14 years. Temporal trends of hospitalizations by sex The annual number of hospitalizations ranged from 64 cases in 2016 to 113 in 2019, followed by a slight decrease during 2020–2021 and a subsequent increase to 106 cases in 2023 (Fig. 1). Fig. 1(A) Hospitalizations for schistosomiasis in Spain by sex and year, and (B) hospitalization rates per million hospital admissions (2016–2023) (A) Hospitalizations for schistosomiasis in Spain by sex and year, and (B) hospitalization rates per million hospital admissions (2016–2023) The overall hospitalization rate was 20.0 per million hospital admissions during the study period. The rate increased from 14.6 per million in 2016 to a peak of 24.8 per million in 2019, after which it slightly declined and remained relatively stable between 21 and 23 per million hospital admissions from 2020 onwards. When stratified by sex, hospitalization rates were consistently higher in men than in women throughout the study period, with an overall rate of 32.1 per million hospital admissions in men compared with 8.7 per million in women. Baseline characteristics of the study population by sex The median age of patients was 36 years (IQR 24–51). Women were significantly older than men (median age 46 vs. 34 years, p < 0.001). Of the 710 hospitalizations, the country of birth was available in 568 (434 males and 134 females). Spain was the most frequent country of origin (46.7%), followed by Mali (14.6%), Senegal (9.2%), and Equatorial Guinea (4.4%). Other countries with smaller numbers of cases included Morocco, Gambia, Ivory Coast, Bolivia, and Guinea. Men predominated among patients born in most sub-Saharan African countries, whereas a relatively higher proportion of women was observed among patients born in Equatorial Guinea (Table S2). Most hospitalizations occurred as unplanned admissions (69.7%), which were more frequent among women than men (79.7% vs. 66.8%, p = 0.002). Schistosomiasis was recorded as the primary diagnosis in 22.8% of hospitalizations, and in diagnostic positions 1–3 in 54.9% of cases. Schistosoma haematobium infection was the most frequently identified species (28.9% of hospitalizations), being significantly more common in men (33.3% vs. 13.8%, p < 0.001), whereas S. mansoni infection accounted for 7.3% of cases. Other or unspecified schistosomiasis codes represented 64.5% of hospitalizations and were more frequent among women (77.5% vs. 60.7%, p < 0.001). Coinfections and comorbidities were relatively frequent. Malaria was identified in 5.2% of hospitalizations, tuberculosis in 7.2%, and HIV infection in 4.8%. Chronic viral hepatitis B or C was present in 12.0% of patients and was more common in men (13.3% vs. 7.5%, p = 0.048). Hypertension (22.4%) and diabetes mellitus (10.3%) were among the most common chronic conditions. Women showed higher frequencies of hypertension (32.5% vs. 19.5%, p < 0.001) and obesity (8.8% vs. 1.3%, p < 0.001) (Table 1). Table 1Clinical characteristics of hospitalizations with schistosomiasis according to sexVariableTotal(N = 710)N (%)Male(N = 550)N (%)Female(N = 160)N (%)p value*** Demographic Age, median (IQR), years36 (24–51)34 (23–48)46 (30–62) < 0.001 Age ≤ 14 years38(6.9)12(7.5)50(7.0)0.789 Type of schistosomiasis infection S. haematobium infection205 (28.9)183 (33.3)22 (13.8) < 0.001 S. mansoni infection52 (7.3)38 (6.9)14 (8.8)0.431Another schistosomiasis*458 (64.5)334 (60.7)124 (77.5) < 0.001 Diagnostic position of schistosomiasis Coded as primary diagnosis162 (22.8)135 (24.5)27 (16.9) 0.042 Coded in positions 1–3390 (54.9)317 (57.6)73 (45.6) 0.007 Imported comorbidities Chronic viral hepatitis B and/or C85 (12.0)73 (13.3)12 (7.5) 0.048 Tuberculosis51 (7.2)44 (8.0)7 (4.4)0.118Malaria37 (5.2)28 (5.1)9 (5.6)0.789HIV infection34 (4.8)22 (4.0)12 (7.5)0.068Helminth infections**30 (4.2)20 (3.6)10 (6.3)0.148 General comorbidities Hypertension159 (22.4)107 (19.5)52 (32.5) < 0.001 Diabetes mellitus73 (10.3)50 (9.1)23 (14.4)0.053Chronic kidney disease76 (10.7)58 (10.5)18 (11.3)0.800Neoplasia62 (8.7)55 (10.0)7 (4.4) 0.027 Obesity21 (3.0)7 (1.3)14 (8.8)< 0.001 Hospitalization outcomes Unplanned admission493 (69.7)367 (66.8)126 (79.7) 0.002 ICU admission61 (8.6)49 (8.9)12 (7.5)0.572In-hospital mortality13 (1.8)9 (1.6)4 (2.5)0.473Length of hospital stay, median (IQR), days8 (3–17)7 (2–17)9 (4–17.5) 0.041 Cost of hospitalization Median (IQR), €4400 (3300–6500)4294.5 (3204–6304)4764.5 (3573–6903)0.08Abbreviations: HIV, human immunodeficiency virus; ICU, intensive care unit; IQR, interquartile range; S., SchistosomaNotes: Values are expressed as n (%) within sex. *Another schistosomiasis includes unspecified or other species of schistosomiasis. ** Helminth infections include other parasitic worm infections different from schistosomiasis. ***p values were calculated using the chi-square test or Fisher’s exact test for categorical variables and the Mann–Whitney U test for continuous variables. Values with p < 0.05 are shown in bold Table 1Clinical characteristics of hospitalizations with schistosomiasis according to sexVariableTotal(N = 710)N (%)Male(N = 550)N (%)Female(N = 160)N (%)p value*** Demographic Age, median (IQR), years36 (24–51)34 (23–48)46 (30–62) < 0.001 Age ≤ 14 years38(6.9)12(7.5)50(7.0)0.789 Type of schistosomiasis infection S. haematobium infection205 (28.9)183 (33.3)22 (13.8) < 0.001 S. mansoni infection52 (7.3)38 (6.9)14 (8.8)0.431Another schistosomiasis*458 (64.5)334 (60.7)124 (77.5) < 0.001 Diagnostic position of schistosomiasis Coded as primary diagnosis162 (22.8)135 (24.5)27 (16.9) 0.042 Coded in positions 1–3390 (54.9)317 (57.6)73 (45.6) 0.007 Imported comorbidities Chronic viral hepatitis B and/or C85 (12.0)73 (13.3)12 (7.5) 0.048 Tuberculosis51 (7.2)44 (8.0)7 (4.4)0.118Malaria37 (5.2)28 (5.1)9 (5.6)0.789HIV infection34 (4.8)22 (4.0)12 (7.5)0.068Helminth infections**30 (4.2)20 (3.6)10 (6.3)0.148 General comorbidities Hypertension159 (22.4)107 (19.5)52 (32.5) < 0.001 Diabetes mellitus73 (10.3)50 (9.1)23 (14.4)0.053Chronic kidney disease76 (10.7)58 (10.5)18 (11.3)0.800Neoplasia62 (8.7)55 (10.0)7 (4.4) 0.027 Obesity21 (3.0)7 (1.3)14 (8.8)< 0.001 Hospitalization outcomes Unplanned admission493 (69.7)367 (66.8)126 (79.7) 0.002 ICU admission61 (8.6)49 (8.9)12 (7.5)0.572In-hospital mortality13 (1.8)9 (1.6)4 (2.5)0.473Length of hospital stay, median (IQR), days8 (3–17)7 (2–17)9 (4–17.5) 0.041 Cost of hospitalization Median (IQR), €4400 (3300–6500)4294.5 (3204–6304)4764.5 (3573–6903)0.08Abbreviations: HIV, human immunodeficiency virus; ICU, intensive care unit; IQR, interquartile range; S., SchistosomaNotes: Values are expressed as n (%) within sex. *Another schistosomiasis includes unspecified or other species of schistosomiasis. ** Helminth infections include other parasitic worm infections different from schistosomiasis. ***p values were calculated using the chi-square test or Fisher’s exact test for categorical variables and the Mann–Whitney U test for continuous variables. Values with p < 0.05 are shown in bold Clinical characteristics of hospitalizations with schistosomiasis according to sex Abbreviations: HIV, human immunodeficiency virus; ICU, intensive care unit; IQR, interquartile range; S., Schistosoma Notes: Values are expressed as n (%) within sex. *Another schistosomiasis includes unspecified or other species of schistosomiasis. ** Helminth infections include other parasitic worm infections different from schistosomiasis. ***p values were calculated using the chi-square test or Fisher’s exact test for categorical variables and the Mann–Whitney U test for continuous variables. Values with p < 0.05 are shown in bold Clinical characteristics and outcomes by sex Clinical outcomes showed only modest differences between men and women (Table 1). The median length of hospital stay was 8 days (IQR 3–17) overall and was slightly longer among women than men (9 vs. 7 days, p = 0.041). Admission to the intensive care unit occurred in 61 hospitalizations (8.6%), with no statistically significant differences between men and women. Overall, in-hospital mortality was low (1.8%), corresponding to 13 deaths during hospitalization, and did not differ significantly by sex. Genitourinary complications by sex and type of infection Urological complications were relatively frequent. Chronic kidney disease was recorded in 76 hospitalizations (10.7%) and acute kidney injury in 66 (9.3%), without significant differences between sexes. Other urological manifestations included cystitis (5.4%), hematuria (4.8%), bladder cancer (4.1%), and obstructive uropathy (4.1%) (Table 2). No cases of male or female infertility were coded in the database. Table 2Urological, hepatosplenic and colonic complications among patients hospitalized according to sexComplicationTotal(N = 710)N (%)Male(N = 550)N (%)Female(N = 160)N (%)p value Urological complications Chronic kidney disease76 (10.7)58 (10.5)18 (11.3)0.800Acute kidney injury66 (9.3)48 (8.7)18 (11.3)0.333Cystitis38 (5.4)37 (6.7)1 (0.6) 0.003 Hematuria34 (4.8)32 (5.8)2 (1.3) 0.017 Bladder cancer29 (4.1)28 (5.1)1 (0.6) 0.012 Obstructive uropathy / ureteral complications29 (4.1)29 (5.3)0 (0.0) 0.003 Urinary tract infection / pyelonephritis4 (0.6)2 (0.4)2 (1.3)0.187Prostatitis3 (0.4)3 (0.5)0 (0.0)0.349Infertility0 (0.0)0 (0.0)0 (0.0)- Hepatosplenic complications Portal hypertension45 (6.3)25 (4.5)20 (12.5) < 0.001 Cirrhosis25 (3.5)15 (2.7)10 (6.3) 0.033 Esophageal varices25 (3.5)10 (1.8)15 (9.4) < 0.001 Splenomegaly17 (2.4)8 (1.5)9 (5.6) 0.002 Intestinal complications Colitis11 (1.5)6 (1.1)5 (3.1)0.067Gastrointestinal bleeding3 (0.4)2 (0.4)1 (0.6)0.654Colonic polyps1 (0.1)1 (0.2)0 (0.0)0.589Values are expressed as n (%) within sex. Comparisons between sexes were performed using the chi-square test or Fisher’s exact test (when appropriate) for categorical variables. Values with p < 0.05 are shown in bold Table 2Urological, hepatosplenic and colonic complications among patients hospitalized according to sexComplicationTotal(N = 710)N (%)Male(N = 550)N (%)Female(N = 160)N (%)p value Urological complications Chronic kidney disease76 (10.7)58 (10.5)18 (11.3)0.800Acute kidney injury66 (9.3)48 (8.7)18 (11.3)0.333Cystitis38 (5.4)37 (6.7)1 (0.6) 0.003 Hematuria34 (4.8)32 (5.8)2 (1.3) 0.017 Bladder cancer29 (4.1)28 (5.1)1 (0.6) 0.012 Obstructive uropathy / ureteral complications29 (4.1)29 (5.3)0 (0.0) 0.003 Urinary tract infection / pyelonephritis4 (0.6)2 (0.4)2 (1.3)0.187Prostatitis3 (0.4)3 (0.5)0 (0.0)0.349Infertility0 (0.0)0 (0.0)0 (0.0)- Hepatosplenic complications Portal hypertension45 (6.3)25 (4.5)20 (12.5) < 0.001 Cirrhosis25 (3.5)15 (2.7)10 (6.3) 0.033 Esophageal varices25 (3.5)10 (1.8)15 (9.4) < 0.001 Splenomegaly17 (2.4)8 (1.5)9 (5.6) 0.002 Intestinal complications Colitis11 (1.5)6 (1.1)5 (3.1)0.067Gastrointestinal bleeding3 (0.4)2 (0.4)1 (0.6)0.654Colonic polyps1 (0.1)1 (0.2)0 (0.0)0.589Values are expressed as n (%) within sex. Comparisons between sexes were performed using the chi-square test or Fisher’s exact test (when appropriate) for categorical variables. Values with p < 0.05 are shown in bold Urological, hepatosplenic and colonic complications among patients hospitalized according to sex Values are expressed as n (%) within sex. Comparisons between sexes were performed using the chi-square test or Fisher’s exact test (when appropriate) for categorical variables. Values with p < 0.05 are shown in bold These complications were significantly more frequent in men, particularly bladder cancer (5.1% vs. 0.6%, p = 0.012), hematuria (5.8% vs. 1.3%, p = 0.017), cystitis (6.7% vs. 0.6%, p = 0.003), and obstructive uropathy (5.3% vs. 0.0%, p = 0.003). In the multivariable analysis adjusted for age, sex, comorbidities, and schistosomiasis type, male sex had a significantly higher likelihood of bladder cancer (adjusted OR 16.31, 95% CI 2.12–125; p = 0. 0.007) and cystitis (adjusted OR 9.49, 95% CI 1.28–70; p = 0.028) compared with women. In contrast, male sex was not significantly associated with hematuria or obstructive uropathy (Table 3). Age was positively associated with bladder cancer (adjusted OR per year increase 1.05, 95% CI 1.043–1.08; p < 0.001), while increasing age was associated with a lower probability of hematuria. (adjusted OR 0.96, 95% CI 0.93–0.99; p = 0.005). Table 3Multivariable logistic regression models for genitourinary complications among patients hospitalized with schistosomiasis in SpainVariableBladder cancerHematuriaCystitisObstructive uropathyaOR (95% CI)p-valueaOR (95% CI)p-valueaOR (95% CI)p-valueaOR (95% CI)p-valueMale sex (vs. female) 16.31 (2.12–125) 0.007 3.33 (0.77–14.35)0.107 9.49 (1.28–70) 0.028 —0.995Age (per year increase) 1.05 (1.03–1.07) <0.001 0.96 (0.93–0.99) 0.005 0.99 (0.97–1.01)0.2260.99 (0.96–1.01)0.226Schistosomiasis coded in positions 1–30.94 (0.43–2.08)0.8872.18 (0.86–5.57)0.1021.90 (0.87–4.15)0.1090.58 (0.26–1.30)0.185Hypertension0.74 (0.30–1.86)0.527—0.9960.95 (0.32–2.83)0.9261.61 (0.58–4.45)0.358Chronic viral hepatitis B/C0.60 (0.13–2.68)0.5020.70 (0.16–3.12)0.6360.95 (0.32–2.83)0.9210.40 (0.09–1.73)0.217aOR (95% CI) indicates adjusted odds ratio with 95% confidence interval obtained from multivariable logistic regression models; B/C, hepatitis B or C. Values with p < 0.05 are shown in bold Table 3Multivariable logistic regression models for genitourinary complications among patients hospitalized with schistosomiasis in SpainVariableBladder cancerHematuriaCystitisObstructive uropathyaOR (95% CI)p-valueaOR (95% CI)p-valueaOR (95% CI)p-valueaOR (95% CI)p-valueMale sex (vs. female) 16.31 (2.12–125) 0.007 3.33 (0.77–14.35)0.107 9.49 (1.28–70) 0.028 —0.995Age (per year increase) 1.05 (1.03–1.07) <0.001 0.96 (0.93–0.99) 0.005 0.99 (0.97–1.01)0.2260.99 (0.96–1.01)0.226Schistosomiasis coded in positions 1–30.94 (0.43–2.08)0.8872.18 (0.86–5.57)0.1021.90 (0.87–4.15)0.1090.58 (0.26–1.30)0.185Hypertension0.74 (0.30–1.86)0.527—0.9960.95 (0.32–2.83)0.9261.61 (0.58–4.45)0.358Chronic viral hepatitis B/C0.60 (0.13–2.68)0.5020.70 (0.16–3.12)0.6360.95 (0.32–2.83)0.9210.40 (0.09–1.73)0.217aOR (95% CI) indicates adjusted odds ratio with 95% confidence interval obtained from multivariable logistic regression models; B/C, hepatitis B or C. Values with p < 0.05 are shown in bold Multivariable logistic regression models for genitourinary complications among patients hospitalized with schistosomiasis in Spain aOR (95% CI) indicates adjusted odds ratio with 95% confidence interval obtained from multivariable logistic regression models; B/C, hepatitis B or C. Values with p < 0.05 are shown in bold In the univariate analysis, bladder cancer (8.3% vs. 2.4%, p < 0.001), hematuria (11.2% vs. 2.2%; p < 0.001), cystitis (10.7% vs. 3.2%, p < 0.001), and obstructive uropathy or ureteral complications (7.8% vs. 2.6%, p = 0.001) were significantly associated with S. haematobium. In the multivariable analysis adjusted for age, sex, comorbidities, male sex remained independently associated with bladder cancer (adjusted OR 13.82, 95% CI 1.72–111.36; p = 0.014) and cystitis (adjusted OR 7.68, 95% CI 1.03–57.27; p = 0.047), whereas the association with hematuria was not statistically significant (Table S3). Hepatosplenic and colonic complications by sex and type of infection Hepatosplenic complications were less common but showed marked sex differences. Portal hypertension was identified in 6.3% of hospitalizations and was significantly more frequent in women than men (12.5% vs. 4.5%, p < 0.001). Similarly, esophageal varices (9.4% vs. 1.8%, p < 0.001), splenomegaly (5.6% vs. 1.5%, p = 0.002), and cirrhosis (6.3% vs. 2.7%, p = 0.033) were more frequent among women. Intestinal complications were rare. Colitis was identified in 1.5% of hospitalizations and tended to be more frequent in women. Gastrointestinal bleeding was uncommon (0.4%) and did not differ significantly by sex, while colonic polyps were recorded in only one case. In the multivariable analysis of hepatosplenic complications, women had higher odds of portal hypertension (adjusted OR 3.10, 95% CI 1.60–5.99; p = 0.001), esophageal varices (adjusted OR 7.11, 95% CI 2.92–17.30; p < 0.001), and splenomegaly (adjusted OR 5.46, 95% CI 1.88–15.92; p = 0.002). Chronic viral hepatitis B or C was independently associated with cirrhosis or hepatic fibrosis (adjusted OR 2.78, 95% CI 1.05–7.40; p = 0.040) and splenomegaly (adjusted OR 4.73, 95% CI 1.51–14.85; p = 0.008). Hypertension was inversely associated with portal hypertension (adjusted OR 0.31, 95% CI 0.11–0.88; p = 0.027 (Table 4). Table 4Multivariable logistic regression models for hepatosplenic complications among patients hospitalized with schistosomiasis in SpainVariableCirrhosis / hepatic fibrosis aOR (95% CI)p-valuePortal hypertension aOR (95% CI)p-valueEsophageal varices aOR (95% CI)p-valueSplenomegaly aOR (95% CI)p-valueFemale sex (vs. male)1.72 (0.70–4.23)0.241 3.10 (1.60–5.99) 0.001 7.11 (2.92–17.30) <0.001 5.46 (1.88–15.92) 0.002 Age (per year increase)1.02 (0.99–1.04)0.2131.00 (0.98–1.02)0.7190.99 (0.97–1.02)0.6341.00 (0.97–1.03)0.857Schistosomiasis coded in positions 1–30.49 (0.19–1.26)0.1380.91 (0.47–1.77)0.7851.21 (0.50–2.95)0.6780.41 (0.13–1.32)0.135Hypertension0.80 (0.29–2.16)0.6520.31 (0.11–0.88)0.0270.21 (0.04–1.03)0.0540.13 (0.02–1.09)0.060Obesity2.87 (0.69–12.02)0.1491.39 (0.27–7.02)0.6940.98 (0.11–9.22)0.9881.34 (0.13–14.24)0.806Chronic viral hepatitis B/C 2.78 (1.05–7.40) 0.040 1.56 (0.63–3.83)0.3342.85 (0.93–8.77)0.0684.73 (1.51–14.85)0.008Other schistosomiasis types2.92 (0.84–10.14)0.0922.49 (1.11–5.59)0.0272.00 (0.71–5.66)0.1930.88 (0.28–2.73)0.818Notes: aOR (95% CI) indicates adjusted odds ratio with 95% confidence interval obtained from multivariable logistic regression models. OR, odds ratio; CI, confidence interval; B/C, hepatitis B or C. Values with p < 0.05 are shown in bold Table 4Multivariable logistic regression models for hepatosplenic complications among patients hospitalized with schistosomiasis in SpainVariableCirrhosis / hepatic fibrosis aOR (95% CI)p-valuePortal hypertension aOR (95% CI)p-valueEsophageal varices aOR (95% CI)p-valueSplenomegaly aOR (95% CI)p-valueFemale sex (vs. male)1.72 (0.70–4.23)0.241 3.10 (1.60–5.99) 0.001 7.11 (2.92–17.30) <0.001 5.46 (1.88–15.92) 0.002 Age (per year increase)1.02 (0.99–1.04)0.2131.00 (0.98–1.02)0.7190.99 (0.97–1.02)0.6341.00 (0.97–1.03)0.857Schistosomiasis coded in positions 1–30.49 (0.19–1.26)0.1380.91 (0.47–1.77)0.7851.21 (0.50–2.95)0.6780.41 (0.13–1.32)0.135Hypertension0.80 (0.29–2.16)0.6520.31 (0.11–0.88)0.0270.21 (0.04–1.03)0.0540.13 (0.02–1.09)0.060Obesity2.87 (0.69–12.02)0.1491.39 (0.27–7.02)0.6940.98 (0.11–9.22)0.9881.34 (0.13–14.24)0.806Chronic viral hepatitis B/C 2.78 (1.05–7.40) 0.040 1.56 (0.63–3.83)0.3342.85 (0.93–8.77)0.0684.73 (1.51–14.85)0.008Other schistosomiasis types2.92 (0.84–10.14)0.0922.49 (1.11–5.59)0.0272.00 (0.71–5.66)0.1930.88 (0.28–2.73)0.818Notes: aOR (95% CI) indicates adjusted odds ratio with 95% confidence interval obtained from multivariable logistic regression models. OR, odds ratio; CI, confidence interval; B/C, hepatitis B or C. Values with p < 0.05 are shown in bold Multivariable logistic regression models for hepatosplenic complications among patients hospitalized with schistosomiasis in Spain Notes: aOR (95% CI) indicates adjusted odds ratio with 95% confidence interval obtained from multivariable logistic regression models. OR, odds ratio; CI, confidence interval; B/C, hepatitis B or C. Values with p < 0.05 are shown in bold Geographical distribution by sex The geographic distribution of hospitalizations showed marked regional differences across Spain (Table S4). The largest numbers of hospitalizations were recorded in Catalonia (27.7%), Andalusia (18.9%), and the Community of Madrid (16.6%), which together accounted for more than half of all cases. Men accounted for most hospitalizations in most autonomous communities. This predominance was particularly evident in Catalonia (156 men vs. 41 women), Andalusia (116 vs. 18), and the Valencian Community (40 vs. 7). However, in some regions the proportion of women was relatively higher, particularly in the Community of Madrid (38 women vs. 80 men), the Balearic Islands (9 women vs. 6 men), and Galicia (7 women vs. 11 men). When hospitalization rates were calculated per 100,000 hospitalizations, substantial variability between regions was observed. The highest overall rates were observed in Catalonia (3.32 per 100,000 hospitalizations), Andalusia (2.85), Aragon (2.28), the Canary Islands (2.22), the Community of Madrid (2.16). and the Basque Country (2.15), and In most regions, hospitalization rates were higher among men than women. Hospitalization costs by sex The median cost of hospitalization was €4,400 (IQR €3,300–€6,500), without significant differences between men and women (€4,294.5 vs. €4,764.5, p = 0.1) (Table 1). Discussion This study highlights the predominance of men among patients hospitalized with schistosomiasis in Spain throughout the study period, as well as higher hospitalization rates among men compared with women. Schistosomiasis was recorded as the primary diagnosis in approximately one quarter of hospitalizations and among the first three diagnostic positions in more than half of the cases, suggesting that in a substantial proportion of admissions it was not the main reason for hospitalization but rather a condition identified during the hospital stay. Overall mortality was low, although women had slightly longer hospital stays. Importantly, clear sex-related differences were observed in the pattern of complications, with men presenting more frequently with genitourinary manifestations and women with hepatosplenic complications. In addition, a heterogeneous geographic distribution of hospitalizations was observed across Spain. Pediatric cases represented a small proportion of hospitalizations, with only 7.0% of patients aged ≤ 14 years. This finding is consistent with the epidemiology of imported schistosomiasis in Europe, where most cases occur in adult migrants or travelers from endemic regions [12]. The predominance of men in this cohort is consistent with previous studies of imported schistosomiasis in Europe and Spain, where most cases have been described in male migrants from endemic areas of sub-Saharan Africa [5, 7, 8]. A large European surveillance study found that more than half of cases occurred in non-European immigrants and that most infections had been acquired in Africa, with men representing the majority of cases [8]. In Spain, a cohort of chronic schistosomiasis patients from Barcelona also showed a marked predominance of men, most of whom originated from sub-Saharan Africa [13]. Several explanations have been proposed for this pattern, including occupational or environmental exposure in endemic regions and the demographic structure of migrant populations in Europe, where men from endemic countries are often overrepresented [5, 8]. Meta-analyses have also demonstrated that males have slightly higher prevalence of both Schistosoma haematobium and Schistosoma mansoni infections, although these differences appear largely related to gender-specific patterns of water contact rather than biological susceptibility [14]. Urogenital complications, including cystitis, hematuria, bladder cancer, and obstructive uropathy, were observed in fewer than 6% of hospitalizations but were significantly more frequent among men. This finding may be explained by the higher proportion of infections due to Schistosoma haematobium in men according to the diagnostic coding used in this study. S. haematobium is classically associated with urogenital disease, including hematuria, chronic cystitis, ureteral obstruction, and an increased risk of bladder carcinoma [1, 3] Although many cases in our database were coded as unspecified schistosomiasis, it is possible that a proportion of these corresponded to infections caused by S. haematobium, which may partially explain the higher frequency of urogenital complications among men. Infertility related to Schistosoma haematobium infection has been described in both men and women [7, 15], but no cases were identified in our series. In contrast, hepatosplenic complications such as portal hypertension, cirrhosis, esophageal varices, and splenomegaly were more common among women in our cohort. These manifestations are typically associated with chronic infection caused by Schistosoma mansoni, which produces periportal fibrosis and portal hypertension in advanced stages of disease [1, 16]. However, our observation of more hepatosplenic complications in women contrasts with several studies from endemic areas, where severe periportal fibrosis has been reported more frequently among men [17]. Several explanations may account for our findings, including potential coding patterns in hospital databases, differences in healthcare-seeking behavior, confounding by other liver diseases such as viral hepatitis, or the relatively small number of severe complications observed. In the multivariable analysis, male sex remained independently associated with bladder cancer and cystitis. This striking sex difference in bladder cancer risk is consistent with evidence from schistosomiasis-endemic regions, where male smokers infected with S. haematobium have a particularly elevated risk [18, 19]. The independent association between male sex and cystitis likely reflects the pathophysiology of S. haematobium infection, in which parasite eggs deposited in the bladder wall induce granulomatous inflammation, ulceration, dysuria, and hematuria [1, 7, 13, 20]. Although hematuria was not independently associated with male sex in our multivariable model, it remains a hallmark manifestation of urogenital schistosomiasis, typically appearing 10–12 weeks after infection and serving as an important clinical indicator of disease [7, 13, 21, 22]. The low overall mortality observed in our study is consistent with the fact that schistosomiasis is associated with considerable morbidity but relatively low mortality in non-endemic settings [23]. In our cohort, the observation that schistosomiasis was recorded as the primary diagnosis in only one quarter of hospitalizations suggests that many patients were admitted for complications or comorbidities, with schistosomiasis being identified during the hospital stay rather than representing the main cause of admission. The heterogeneous geographic distribution of hospitalizations across Spain likely reflects regional differences in the settlement patterns of migrant populations from endemic areas, particularly from sub-Saharan Africa. Higher numbers of hospitalizations were observed in regions such as Catalonia and Madrid, which host some of the largest migrant populations from endemic countries. Catalonia, in particular, has historically received a substantial proportion of migrants from West and Central Africa and has several reference centres in tropical and imported diseases, which may facilitate both diagnosis and hospital management of schistosomiasis. In addition, Andalusia also contributes a notable number of cases, which may partly reflect the large size of the region and its role as an entry point and settlement area for migrants from Africa [24]. Previous studies have also shown that chronic complications may develop in migrants with long-term residence in non-endemic countries when schistosomiasis remains undiagnosed and untreated [5, 7, 13]. These findings highlight the importance of systematic screening strategies in high-risk populations and early treatment in order to prevent progression to severe disease. One strength of this retrospective study is that it is based on a large nationwide hospital discharge database that captures most hospitalizations in Spain, allowing a comprehensive assessment of the burden of schistosomiasis at the national level. In addition, the study provides information on clinical manifestations and complications and specifically explores differences according to sex, offering new insights into the clinical spectrum of schistosomiasis hospitalizations in a non-endemic country. The limitations of this study are mainly related to the use of a medico-administrative database based on diagnostic coding. First, the database records hospital admissions rather than individual patients; therefore, each admission or readmission is considered a separate episode, and some patients may have been included more than once. Second, the available information corresponds to diagnoses coded at hospital discharge, and only those conditions considered clinically relevant may have been recorded, which could lead to underreporting of associated diseases. Another limitation concerns the accuracy of diagnostic coding. Most cases were coded as unspecified schistosomiasis (ICD-10: B65.9), which may reflect limited species identification in clinical practice. As a result, infections due to Schistosoma haematobium or Schistosoma mansoni may have been misclassified. In addition, schistosomiasis was coded as a secondary diagnosis in a considerable proportion of hospitalizations, suggesting that in some cases it may not have been the main reason for admission. Some regression analyses showed wide confidence intervals, probably due to the low frequency of certain complications and the limited number of events in some subgroups, which may have led to model instability and potential overfitting. Therefore, these findings should be interpreted with caution. Information on country of birth was also incomplete or potentially inaccurate. The high proportion of patients recorded as being born in Spain may reflect incomplete data collection or misclassification, which limits the ability to distinguish imported infections in migrants or in travelers [3, 5, 7]. Finally, because this was a retrospective study based on administrative data, we were unable to review individual medical records to verify the accuracy of the coded information. Conclusions In conclusion, data from a national medico-administrative database provide valuable insight into the burden and clinical patterns of schistosomiasis in Spain. Hospitalizations predominantly affect men and are largely associated with infections acquired in endemic regions. Differences in the pattern of complications between men and women were observed, with genitourinary manifestations being more frequently recorded in men and hepatosplenic complications more commonly identified in women. However, given that a substantial proportion of cases were classified as “other” or “unspecified” schistosomiasis, these findings should be interpreted with caution, particularly regarding species-specific associations. Overall, these findings highlight the heterogeneous clinical presentation of schistosomiasis in a non-endemic setting and underscore the importance of maintaining clinical awareness and considering schistosomiasis in at-risk populations in non-endemic countries. From a clinical and public health perspective, these findings support the need for increased awareness among healthcare professionals, improved diagnostic strategies, and targeted screening approaches in high-risk populations to facilitate earlier diagnosis and prevent long-term complications. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1